mProX™ Human LIMK1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Emily
Verified Customer
Rebecca
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Nuclear LIMK1 contributes to the aggressive phenotype of HCC cells in vitro.
The expression of LIMK1 in HCC cell lines was shown by Western blot analysis, and the relative protein abundance was calculated by normalizing to GAPDH.
Ref: Pan, Zhihua, et al. "LIMK1 nuclear translocation promotes hepatocellular carcinoma progression by increasing p-ERK nuclear shuttling and by activating c-Myc signalling upon EGF stimulation." Oncogene 40.14 (2021): 2581-2595.
Pubmed: 33686242
DOI: 10.1038/s41388-021-01736-2
Research Highlights
Actin dynamics is mostly regulated by LIM domain kinase 1 (LIMK1). Thus, it presents a possible therapeutic target for the avoidance of amyotrophic lateral sclerosis and fragile X syndrome.
Salah, Eidarus, et al. "Lessons from LIMK1 enzymology and their impact on inhibitor design." Biochemical Journal 476.21 (2019): 3197-3209.
Pubmed:
31652302
DOI:
10.1042/BCJ20190517
One common type of metastasis among individuals with advanced gastric cancer is peritoneal metastasis. The present investigation has revealed that LIM domain kinase 1 (LIMK1) is a promising therapeutic target for dabrafenib (DAB) and has been identified as a promoter of gastric cancer peritoneal metastasis.
Kang, Xi, et al. "LIMK1 promotes peritoneal metastasis of gastric cancer and is a therapeutic target." Oncogene 40.19 (2021): 3422-3433.
Pubmed:
33883692
DOI:
10.1038/s41388-021-01656-1